Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan ter Meulen

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
NPJ Vaccines|February 2, 2018
Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trialStéphane Pillet, Éric Aubin, Sonia Trépanier, et al.
Vaccine|February 24, 2020
Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccineTina Chang Albershardt, Andrea Jean Parsons, Rebecca Susan Reeves, et al.
Plos One|December 2, 2021
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memoryJardin A Leleux, Tina C Albershardt, Rebecca Reeves, et al.
Journal of Virology|September 28, 2012
Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challengeGayathri Bommakanti, Xianghan Lu, Michael P Citron, et al.
Virology|March 23, 2004
Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clonesJan ter Meulen, Marlis Badusche, Judith Satoguina, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 12, 2017
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma PatientSeth M Pollack, Hailing Lu, Sacha Gnjatic, et al.
Plos One|March 24, 2016
A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine CandidatesDhanasekaran Govindarajan, Liming Guan, Steven Meschino, et al.
Journal of Virology|January 21, 2009
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticlesFrançois-Loic Cosset, Philippe Marianneau, Geraldine Verney, et al.
Journal of Clinical Microbiology|April 9, 2004
First international quality assurance study on the rapid detection of viral agents of bioterrorismMatthias Niedrig, Herbert Schmitz, Stephan Becker, et al.
Journal of Virology|January 27, 2012
Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantavirusesBoris Klempa, Peter T Witkowski, Elena Popugaeva, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
NPJ Vaccines|February 2, 2018
Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trialStéphane Pillet, Éric Aubin, Sonia Trépanier, et al.
Vaccine|February 24, 2020
Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccineTina Chang Albershardt, Andrea Jean Parsons, Rebecca Susan Reeves, et al.
Plos One|December 2, 2021
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memoryJardin A Leleux, Tina C Albershardt, Rebecca Reeves, et al.
Journal of Virology|September 28, 2012
Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challengeGayathri Bommakanti, Xianghan Lu, Michael P Citron, et al.
Virology|March 23, 2004
Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clonesJan ter Meulen, Marlis Badusche, Judith Satoguina, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 12, 2017
First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma PatientSeth M Pollack, Hailing Lu, Sacha Gnjatic, et al.
Plos One|March 24, 2016
A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine CandidatesDhanasekaran Govindarajan, Liming Guan, Steven Meschino, et al.
Journal of Virology|January 21, 2009
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticlesFrançois-Loic Cosset, Philippe Marianneau, Geraldine Verney, et al.
Journal of Clinical Microbiology|April 9, 2004
First international quality assurance study on the rapid detection of viral agents of bioterrorismMatthias Niedrig, Herbert Schmitz, Stephan Becker, et al.
Journal of Virology|January 27, 2012
Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantavirusesBoris Klempa, Peter T Witkowski, Elena Popugaeva, et al.
Pageof 6